E_N_T_R_O_P_Y: Monocentric analysis of rectal cancer radio-chemotherapy treatment in patients of young age

Purpose//objectives: A disproportionate incidence‘s increase of rectal cancer in patients younger than 50 years of age. The ESMO and NCCN recommendations are not age-specific and the literature is poor and conflicting. We decided to examine patients with rectal cancer treated in our centre in the la...

Full description

Saved in:
Bibliographic Details
Main Authors: E. Meldolesi, A. Nicolì, N. Dinapoli, G. Chiloiro, A. Romano, R. Menghi, R. Persiani, F. Pacelli, C. Coco, C. Ratto, S. Manfrida, L. Boldrini, B. Corvari, M.A. Gambacorta
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630824001824
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832582190810005504
author E. Meldolesi
A. Nicolì
N. Dinapoli
G. Chiloiro
A. Romano
R. Menghi
R. Persiani
F. Pacelli
C. Coco
C. Ratto
S. Manfrida
L. Boldrini
B. Corvari
M.A. Gambacorta
author_facet E. Meldolesi
A. Nicolì
N. Dinapoli
G. Chiloiro
A. Romano
R. Menghi
R. Persiani
F. Pacelli
C. Coco
C. Ratto
S. Manfrida
L. Boldrini
B. Corvari
M.A. Gambacorta
author_sort E. Meldolesi
collection DOAJ
description Purpose//objectives: A disproportionate incidence‘s increase of rectal cancer in patients younger than 50 years of age. The ESMO and NCCN recommendations are not age-specific and the literature is poor and conflicting. We decided to examine patients with rectal cancer treated in our centre in the last 15 years with curative neoadjuvant radiochemotherapy comparing outcomes in the two groups under and over 55 years old. Materials/methods: 788 rectal cancer patients were enrolled in this monocentric retrospective observational study (523 =>55 years and 265 < 55). All patients received neoadjuvant chemoradiation treatment. R statistical software v.4.1.3 was used for the entire analysis. The outcomes were death, local recurrence, and new distant metastases. Survival analysis was performed using the Kaplan-Meier method and the Log-rank was used to compare the two groups. Results: All patients were classified in different risk groups, according to the ESMO 2017 rectal cancer clinical practice guidelines. 88 % of patients under 55 years old at the diagnosis belonged to the bad or advanced risk groups with an equal division. In patients over 55 years old, there was a clear dominance of the advanced risk class (62 % of the total). In multivariate analysis, OS and DFS decrease with increasing age and ESMO risk group. The other variables in multivariate were not significant. For Both OS, DFS and MFS, the curves separated significantly at 55 years of age, with a prevalence of metastasis development in the older group. Conclusion: Elderly patients have a prevalence of advanced disease. Younger patients seem having a better OS at 3 and 5 years. ESMO risk group and age were the only variables affecting OS and DFS. Young patients have better MFS and DFS at 2 and 5 years than patients older than 55 years. The addition of oxaliplatin to fluoropyrimidine-based neoadjuvant chemotherapy resulted not significant in both groups.
format Article
id doaj-art-bc92153715024a45bb9519ff5228bbb6
institution Kabale University
issn 2405-6308
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Clinical and Translational Radiation Oncology
spelling doaj-art-bc92153715024a45bb9519ff5228bbb62025-01-30T05:14:27ZengElsevierClinical and Translational Radiation Oncology2405-63082025-03-0151100905E_N_T_R_O_P_Y: Monocentric analysis of rectal cancer radio-chemotherapy treatment in patients of young ageE. Meldolesi0A. Nicolì1N. Dinapoli2G. Chiloiro3A. Romano4R. Menghi5R. Persiani6F. Pacelli7C. Coco8C. Ratto9S. Manfrida10L. Boldrini11B. Corvari12M.A. Gambacorta13Department of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario ''A. Gemelli'' IRCCS, Rome, ItalyDepartment of Palliative Care, ASL Lecce, San Cesario di Lecce, Lecce, Italy; Corresponding author.Department of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario ''A. Gemelli'' IRCCS, Rome, ItalyDepartment of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario ''A. Gemelli'' IRCCS, Rome, ItalyDepartment of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario ''A. Gemelli'' IRCCS, Rome, ItalyDigestive Surgery Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, ItalyDigestive Surgery Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, ItalyDigestive Surgery Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, ItalyDigestive Surgery Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, ItalyProctology and Pelvic Floor Surgery Unit, Center of Excellence for Gastrointestinal and Endocrine-Metabolic Diseases, Isola Tiberina - Gemelli Isola Hospital, Rome, ItalyDepartment of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario ''A. Gemelli'' IRCCS, Rome, ItalyDepartment of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario ''A. Gemelli'' IRCCS, Rome, ItalyDepartment of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario ''A. Gemelli'' IRCCS, Rome, ItalyDepartment of Diagnostic Imaging, Radiation Oncology and Haematology, Fondazione Policlinico Universitario ''A. Gemelli'' IRCCS, Rome, ItalyPurpose//objectives: A disproportionate incidence‘s increase of rectal cancer in patients younger than 50 years of age. The ESMO and NCCN recommendations are not age-specific and the literature is poor and conflicting. We decided to examine patients with rectal cancer treated in our centre in the last 15 years with curative neoadjuvant radiochemotherapy comparing outcomes in the two groups under and over 55 years old. Materials/methods: 788 rectal cancer patients were enrolled in this monocentric retrospective observational study (523 =>55 years and 265 < 55). All patients received neoadjuvant chemoradiation treatment. R statistical software v.4.1.3 was used for the entire analysis. The outcomes were death, local recurrence, and new distant metastases. Survival analysis was performed using the Kaplan-Meier method and the Log-rank was used to compare the two groups. Results: All patients were classified in different risk groups, according to the ESMO 2017 rectal cancer clinical practice guidelines. 88 % of patients under 55 years old at the diagnosis belonged to the bad or advanced risk groups with an equal division. In patients over 55 years old, there was a clear dominance of the advanced risk class (62 % of the total). In multivariate analysis, OS and DFS decrease with increasing age and ESMO risk group. The other variables in multivariate were not significant. For Both OS, DFS and MFS, the curves separated significantly at 55 years of age, with a prevalence of metastasis development in the older group. Conclusion: Elderly patients have a prevalence of advanced disease. Younger patients seem having a better OS at 3 and 5 years. ESMO risk group and age were the only variables affecting OS and DFS. Young patients have better MFS and DFS at 2 and 5 years than patients older than 55 years. The addition of oxaliplatin to fluoropyrimidine-based neoadjuvant chemotherapy resulted not significant in both groups.http://www.sciencedirect.com/science/article/pii/S2405630824001824Young rectal cancerRadiochemotherapyJuvenile rectal cancer
spellingShingle E. Meldolesi
A. Nicolì
N. Dinapoli
G. Chiloiro
A. Romano
R. Menghi
R. Persiani
F. Pacelli
C. Coco
C. Ratto
S. Manfrida
L. Boldrini
B. Corvari
M.A. Gambacorta
E_N_T_R_O_P_Y: Monocentric analysis of rectal cancer radio-chemotherapy treatment in patients of young age
Clinical and Translational Radiation Oncology
Young rectal cancer
Radiochemotherapy
Juvenile rectal cancer
title E_N_T_R_O_P_Y: Monocentric analysis of rectal cancer radio-chemotherapy treatment in patients of young age
title_full E_N_T_R_O_P_Y: Monocentric analysis of rectal cancer radio-chemotherapy treatment in patients of young age
title_fullStr E_N_T_R_O_P_Y: Monocentric analysis of rectal cancer radio-chemotherapy treatment in patients of young age
title_full_unstemmed E_N_T_R_O_P_Y: Monocentric analysis of rectal cancer radio-chemotherapy treatment in patients of young age
title_short E_N_T_R_O_P_Y: Monocentric analysis of rectal cancer radio-chemotherapy treatment in patients of young age
title_sort e n t r o p y monocentric analysis of rectal cancer radio chemotherapy treatment in patients of young age
topic Young rectal cancer
Radiochemotherapy
Juvenile rectal cancer
url http://www.sciencedirect.com/science/article/pii/S2405630824001824
work_keys_str_mv AT emeldolesi entropymonocentricanalysisofrectalcancerradiochemotherapytreatmentinpatientsofyoungage
AT anicoli entropymonocentricanalysisofrectalcancerradiochemotherapytreatmentinpatientsofyoungage
AT ndinapoli entropymonocentricanalysisofrectalcancerradiochemotherapytreatmentinpatientsofyoungage
AT gchiloiro entropymonocentricanalysisofrectalcancerradiochemotherapytreatmentinpatientsofyoungage
AT aromano entropymonocentricanalysisofrectalcancerradiochemotherapytreatmentinpatientsofyoungage
AT rmenghi entropymonocentricanalysisofrectalcancerradiochemotherapytreatmentinpatientsofyoungage
AT rpersiani entropymonocentricanalysisofrectalcancerradiochemotherapytreatmentinpatientsofyoungage
AT fpacelli entropymonocentricanalysisofrectalcancerradiochemotherapytreatmentinpatientsofyoungage
AT ccoco entropymonocentricanalysisofrectalcancerradiochemotherapytreatmentinpatientsofyoungage
AT cratto entropymonocentricanalysisofrectalcancerradiochemotherapytreatmentinpatientsofyoungage
AT smanfrida entropymonocentricanalysisofrectalcancerradiochemotherapytreatmentinpatientsofyoungage
AT lboldrini entropymonocentricanalysisofrectalcancerradiochemotherapytreatmentinpatientsofyoungage
AT bcorvari entropymonocentricanalysisofrectalcancerradiochemotherapytreatmentinpatientsofyoungage
AT magambacorta entropymonocentricanalysisofrectalcancerradiochemotherapytreatmentinpatientsofyoungage